Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Clinical trial NCT07363577 · RECRUITING
Trial details
- NCT number
- NCT07363577
- Sponsor
- LB Pharmaceuticals Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-25
- Primary completion
- 2027-06-01
- Enrollment
- 456
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.